HIT Consultant October 3, 2022
Syed Hamza Sohail

What You Should Know:

– In a recent patient-centric survey, SubjectWell found that accommodations for all patients, including free treatment and study compensation, increase interest in clinical trial participation – particularly for patients of color.

– However, overall, using value-based messaging, adding education to the recruiting process and reducing friction to participation – are universally impactful, not just for diverse populations, and that certain barriers affected white patients and patients of color nearly the same.

Exploring Representation in Healthcare Using Patient-Centric Surveys

Minority populations are significantly underrepresented in clinical research. When comparing the FDA’s recent Drug Trial Snapshots data with US Census data, women, white patients, and older patients are shown to be overrepresented in clinical trials. Black patients make...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Equity/SDOH, Healthcare System, Patient / Consumer, Survey / Study, Trends
Eli Lilly Shows Obesity Drug Zepbound Can Treat Sleep Apnea Too
Opinion: Even with new law, clinical trials lack data on older adults
Eli Lilly's tirzepatide scores again, this time in 2 sleep apnea trials
Eli Lilly’s weight loss drug Zepbound shows promise as a sleep apnea treatment in late-stage trials
FDA wants to boost trial innovation with new center at CDER

Share This Article